COPD
FDA Approves Combination Therapy for COPD Maintenance
FDA Approves Combination Therapy for COPD Maintenance
The combination treatment (Duaklir, Circassia) is designed to be administered twice-daily via AstraZeneca’s breath-actuated inhaler (Pressair).
Read More >>
Helping Patients Breathe Easier
Letter from the Chairman: Helping Patients Breathe Easier
Generic Asthma, COPD Treatment Launched at Discounted List Price
Opinion: Pharmacy Profession Needs to Invest in Digital Health This Year
FDA Approves Generic Inhalation Treatment for Asthma, COPD
World's First Smart Inhaler is Arriving
Generic Product News (January 2019)
View more articles >>
Clinical Trials
Muscle Function After Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Preventing Adverse Cardiac Events in COPD
Air Pollution and COPD Exacerbation
COPD Care Model on Clinical and Patient-Reported Outcomes
COPD Discharge Bundle Delivered Alone or Enhanced Through a Care Coordinator
Multimedia: Videos
How to Improve Patient Adherence to Long-Term Asthma and COPD Treatment
How to Improve Patient Adherence to Long-Term Asthma and COPD Treatment
How Pharmacists Can Help Patients Remember Which Medication Is Used for Which Problem
How Pharmacists Can Help Patients Remember Which Medication Is Used for Which Problem
Counseling Points Pharmacists Should Make When Demonstrating Proper Inhaler Use
Counseling Points Pharmacists Should Make When Demonstrating Proper Inhaler Use
How Technology Is Changing the Inhaler Industry
How Technology Is Changing the Inhaler Industry